Arecor Therapeutics plc AREC.L Stock
Arecor Therapeutics plc Price Chart
Arecor Therapeutics plc AREC.L Financial and Trading Overview
| Arecor Therapeutics plc stock price | 137.5 GBP |
| Previous Close | 245 GBP |
| Open | 0 GBP |
| Bid | 230 GBP x N/A |
| Ask | 240 GBP x N/A |
| Day's Range | 0 - 0 GBP |
| 52 Week Range | 0 - 370 GBP |
| Volume | 16.64K GBP |
| Avg. Volume | 3.49K GBP |
| Market Cap | 71.95M GBP |
| Beta (5Y Monthly) | -0.038418 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.31 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 455 GBP |
AREC.L Valuation Measures
| Enterprise Value | 62.5M GBP |
| Trailing P/E | N/A |
| Forward P/E | -13.823529 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 29.942892 |
| Price/Book (mrq) | 412.2807 |
| Enterprise Value/Revenue | 26.008 |
| Enterprise Value/EBITDA | -6.091 |
Trading Information
Arecor Therapeutics plc Stock Price History
| Beta (5Y Monthly) | -0.038418 |
| 52-Week Change | -36.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 370 GBP |
| 52 Week Low | 0 GBP |
| 50-Day Moving Average | 257 GBP |
| 200-Day Moving Average | 249.44 GBP |
AREC.L Share Statistics
| Avg. Volume (3 month) | 3.49K GBP |
| Avg. Daily Volume (10-Days) | 1.86K GBP |
| Shares Outstanding | 30.62M |
| Float | 12.61M |
| Short Ratio | N/A |
| % Held by Insiders | 35.27% |
| % Held by Institutions | 54.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -435.24% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.62% |
| Return on Equity (ttm) | -51.43% |
Income Statement
| Revenue (ttm) | 2.4M GBP |
| Revenue Per Share (ttm) | 0.08 GBP |
| Quarterly Revenue Growth (yoy) | 145.00% |
| Gross Profit (ttm) | 2.4M GBP |
| EBITDA | -10260000 GBP |
| Net Income Avi to Common (ttm) | -9260000 GBP |
| Diluted EPS (ttm) | -0.32 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.81M GBP |
| Total Cash Per Share (mrq) | 0.42 GBP |
| Total Debt (mrq) | 288K GBP |
| Total Debt/Equity (mrq) | 1.65 GBP |
| Current Ratio (mrq) | 4.688 |
| Book Value Per Share (mrq) | 0.57 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10780000 GBP |
| Levered Free Cash Flow (ttm) | -7141125 GBP |
Profile of Arecor Therapeutics plc
| Country | United Kingdom |
| State | N/A |
| City | Little Chesterford |
| Address | Chesterford Research Park |
| ZIP | CB10 1XL |
| Phone | 44 1223 426 060 |
| Website | https://arecor.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 51 |
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo, a ready-to-use glucagon auto-injector pen that is used to treat hypoglycaemia in patients with diabetes; and specialty hospital care products. In addition, the company is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
Q&A For Arecor Therapeutics plc Stock
What is a current AREC.L stock price?
Arecor Therapeutics plc AREC.L stock price today per share is 137.5 GBP.
How to purchase Arecor Therapeutics plc stock?
You can buy AREC.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Arecor Therapeutics plc?
The stock symbol or ticker of Arecor Therapeutics plc is AREC.L.
Which industry does the Arecor Therapeutics plc company belong to?
The Arecor Therapeutics plc industry is Biotechnology.
How many shares does Arecor Therapeutics plc have in circulation?
The max supply of Arecor Therapeutics plc shares is 306.27K.
What is Arecor Therapeutics plc Price to Earnings Ratio (PE Ratio)?
Arecor Therapeutics plc PE Ratio is now.
What was Arecor Therapeutics plc earnings per share over the trailing 12 months (TTM)?
Arecor Therapeutics plc EPS is -0.31 GBP over the trailing 12 months.
Which sector does the Arecor Therapeutics plc company belong to?
The Arecor Therapeutics plc sector is Healthcare.